Clinical Trial Update: Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors

View source ↗

Summary

Sentinel, a prospective study from Strata Oncology evaluating personalized ctDNA-based MRD testing to detect cancer recurrence and monitor treatment response in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Strata Oncology | Conditions: Cancer | Status: TERMINATED